THE EFFECT OF ANTIGEN DOSE ON CD4(+) T-HELPER CELL PHENOTYPE DEVELOPMENT IN A T-CELL RECEPTOR-ALPHA-BETA-TRANSGENIC MODEL

被引:659
作者
HOSKEN, NA
SHIBUYA, K
HEATH, AW
MURPHY, KM
OGARRA, A
机构
[1] UNIV SHEFFIELD, SCH MED, DEPT EXPTL & CLIN MICROBIOL, SHEFFIELD S10 2RX, S YORKSHIRE, ENGLAND
[2] WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA
关键词
D O I
10.1084/jem.182.5.1579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The dose of foreign antigen can influence whether a cell-mediated or humoral class of immune response is elicited, and this may be largely accounted for by the development of CD4(+) T helper cells (Th) producing distinct sets of cytokines. The ability of antigen dose to direct the development of a Th1 or Th2 phenotype from naive CD4(+) T cells, however, has not been demonstrated. In this report, we show that the antigen dose used in primary cultures could directly affect Th phenotype development from naive D011.10 TCR-alpha beta-transgenic CD4(+) T cells when dendritic cells or activated B cells were used as the antigen-presenting cells. Consistent with our previous findings, midrange peptide doses (0.3-0.6 mu M) directed the development of Th0/Th1-like cells, which produced moderate amounts of interferon gamma (IFN-gamma). As the peptide dose was increased, development of Th1-like cells producing increased amounts of IFN-gamma was initially observed. At very high (>10 mu M) and very low (<0.05 mu M) doses of antigenic peptide, however, a dramatic switch to development of Th2-like cells that produced increasing amounts of interleukin 4 (IL-4) and diminishing levels of IFN-gamma was observed. This was true even when highly purified naive, high buoyant density CD4(+) LECAM-1(hi) T cells were used, ruling out a possible contribution from contaminating ''memory'' phenotype CD4(+) T cells. Neutralizing anti-IL-4 antibodies completely inhibited the development of this Th2-like phenotype at both high and low antigen doses, demonstrating a requirement for endogenous IL-4. Our findings suggest that the antigen dose may affect the levels of endogenous cytokines such as IL-4 in primary cultures, resulting in the development of distinct Th cell phenotypes.
引用
收藏
页码:1579 / 1584
页数:6
相关论文
共 30 条
[1]  
ABRAMS J, 1995, CURR PROTOCOLS IMMUN, V13, P1
[2]   FUNCTIONAL-SIGNIFICANCE OF THE REGULATION OF MACROPHAGE-IA EXPRESSION [J].
BELLER, DI .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (02) :138-143
[3]   CHARACTERIZATION OF ANTIGEN-SPECIFIC CD4+ EFFECTOR T-CELLS INVIVO - IMMUNIZATION RESULTS IN A TRANSIENT POPULATION OF MEL-14-, CD45RB- HELPER-CELLS THAT SECRETES INTERLEUKIN-2 (IL-2), IL-3, IL-4, AND INTERFERON-GAMMA [J].
BRADLEY, LM ;
DUNCAN, DD ;
TONKONOGY, S ;
SWAIN, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) :547-559
[4]   ESTABLISHMENT OF STABLE, CELL-MEDIATED-IMMUNITY THAT MAKES SUSCEPTIBLE MICE RESISTANT TO LEISHMANIA-MAJOR [J].
BRETSCHER, PA ;
WEI, GJ ;
MENON, JN ;
BIELEFELDTOHMANN, H .
SCIENCE, 1992, 257 (5069) :539-542
[5]   HETEROGENEITY OF SINGLE-CELL CYTOKINE GENE-EXPRESSION IN CLONAL T-CELL POPULATIONS [J].
BUCY, RP ;
PANOSKALTSISMORTARI, A ;
HUANG, GQ ;
LI, JM ;
KARR, L ;
ROSS, M ;
RUSSELL, JH ;
MURPHY, KM ;
WEAVER, CT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1251-1262
[6]   BEE VENOM PHOSPHOLIPASE-A2-SPECIFIC T-CELL CLONES FROM HUMAN ALLERGIC AND NONALLERGIC INDIVIDUALS - CYTOKINE PATTERNS CHANGE IN RESPONSE TO THE ANTIGEN CONCENTRATION [J].
CARBALLIDO, JM ;
CARBALLIDOPERRIG, N ;
TERRES, G ;
HEUSSER, CH ;
BLASER, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) :1357-1363
[7]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398
[8]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095
[9]  
FIORENTINO DF, 1991, J IMMUNOL, V146, P3444
[10]  
GOLLOB KJ, 1994, J IMMUNOL, V152, P5180